The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 15, 2023

Filed:

May. 21, 2020
Applicants:

Inserm (Institut National DE LA Sante ET DE LA Recherche Medicale), Paris, FR;

Nantes Universite, Nantes, FR;

Universite D'angers, Angers, FR;

Centre National DE LA Recherche Scientifique (Cnrs), Paris, FR;

Inventors:

Pierre-Francois Cartron, Nantes, FR;

Mathilde Cheray, Stockholm, SE;

Francois Valette, Nantes, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/10 (2006.01); G01N 33/574 (2006.01); G01N 33/542 (2006.01); A61K 31/495 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 38/10 (2013.01); G01N 33/542 (2013.01); G01N 33/574 (2013.01); A61K 31/495 (2013.01); A61K 45/06 (2013.01); G01N 2333/4706 (2013.01); G01N 2333/91017 (2013.01);
Abstract

The present invention relates to an in vitro method for determine the prognosis of the survival time of a patient suffering from a cancer comprising the steps consisting of i) determining the expression level of the couple DNMT3A/ISGF3γ in a sample from said patient, ii) comparing said expression level with a predetermined reference value and iii) providing a good prognosis when the expression level is lower than the predetermined reference value and a poor prognosis when the expression level is higher than the predetermined reference value. The invention also relates a compound which is a DNMT3A/ISGF3γ antagonist or a compound which is a DNMT3A/ISGF3γ gene expression inhibitor for use in the treatment and prevention of cancer.


Find Patent Forward Citations

Loading…